Dr. Tabibiazar brings more than 12 years of leadership experience in the healthcare industry, including key executive positions within the biopharmaceutical industry, as well as diagnostics, healthcare IT, and venture capital. In addition to his role at Aravive, he is also the Managing Director of 526 Ventures, a life sciences strategic consulting company working with both public and private biopharmaceutical firms. Prior to joining Aravive, Dr. Tabibiazar was a Venture Partner at Bay City Capital LLC, a large venture capital firm in the Bay Area with more than $1.3 billion under management. Prior to that, Dr. Tabibiazar served as the Chief Scientific Officer of Aviir, a molecular diagnostic company, as well as Vice President of Translational Research of VIA Pharmaceuticals, a cardiovascular therapeutic company. Before moving to industry, Dr. Tabibiazar was a practicing cardiologist and he remains an adjunct clinical instructor in medicine at Stanford University. Dr. Tabibiazar received his medical degree from Harvard Medical School and trained as an internist and cardiologist at Stanford University, while also receiving finance education at Stanford Business School. Dr. Tabibiazar holds board certifications in Internal Medicine, Cardiovascular Medicine, Nuclear Medicine, and Cardiovascular Imaging. He has won numerous honors and research awards and has authored several peer reviewed papers and inventor on more than 20 patents.
Ray Tabibiazar, MD
President and CEO